Biochemical and pharmacological differences between preparations of exogenous natural surfactant used to treat Respiratory Distress Syndrome: role of the different components in an efficient pulmonary surfactant.
about
The Role of Surfactant in Lung Disease and Host Defense against Pulmonary InfectionsSurfactant and its role in the pathobiology of pulmonary infectionThe interplay of lung surfactant proteins and lipids assimilates the macrophage clearance of nanoparticlesComparative study of clinical pulmonary surfactants using atomic force microscopyLung surfactant microbubbles increase lipophilic drug payload for ultrasound-targeted delivery.Surfactant protein SP-B strongly modifies surface collapse of phospholipid vesicles: insights from a quartz crystal microbalance with dissipation.Rediscovering the Schulze-Hardy rule in competitive adsorption to an air-water interfaceEnvironmental tobacco smoke effects on lung surfactant film organization.Aerosolised surfactant generated by a novel noninvasive apparatus reduced acute lung injury in ratsAdministration of antenatal glucocorticoids and postnatal surfactant ameliorates respiratory distress syndrome-associated neonatal lethality in Erk3(-/-) mouse pups.Close mimicry of lung surfactant protein B by "clicked" dimers of helical, cationic peptoids.Meconium impairs pulmonary surfactant by a combined action of cholesterol and bile acids.Surface film formation in vitro by infant and therapeutic surfactants: role of surfactant protein B.Visualizing the analogy between competitive adsorption and colloid stability to restore lung surfactant functionMortality in preterm infants with respiratory distress syndrome treated with poractant alfa, calfactant or beractant: a retrospective study.Clinical and ultrastructural spectrum of diffuse lung disease associated with surfactant protein C mutations.On the low surface tension of lung surfactant.Mechanisms of polyelectrolyte enhanced surfactant adsorption at the air-water interface.Transient exposure of pulmonary surfactant to hyaluronan promotes structural and compositional transformations into a highly active state.Delivery and performance of surfactant replacement therapies to treat pulmonary disorders.Persistence of LPS-induced lung inflammation in surfactant protein-C-deficient micePulmonary surfactant: an immunological perspective.Structure-function correlations of pulmonary surfactant protein SP-B and the saposin-like family of proteins.Lung surfactants and different contributions to thin film stability.Microfluidic shear stress-regulated surfactant secretion in alveolar epithelial type II cells in vitro.The influence of natural pulmonary surfactant on the efficacy of siRNA-loaded dextran nanogels.Combined and independent action of proteins SP-B and SP-C in the surface behavior and mechanical stability of pulmonary surfactant filmsBiomimicry of surfactant protein C.A modified squeeze-out mechanism for generating high surface pressures with pulmonary surfactantThe effect of a C-terminal peptide of surfactant protein B (SP-B) on oriented lipid bilayers, characterized by solid-state 2H- and 31P-NMR.Pulmonary surfactant proteins and polymer combinations reduce surfactant inhibition by serum.Pulmonary surfactant protein SP-C counteracts the deleterious effects of cholesterol on the activity of surfactant films under physiologically relevant compression-expansion dynamics.Pneumocytes Assemble Lung Surfactant as Highly Packed/Dehydrated States with Optimal Surface ActivityPalmitoylation of pulmonary surfactant protein SP-C is critical for its functional cooperation with SP-B to sustain compression/expansion dynamics in cholesterol-containing surfactant films.Effect of Lung Surfactant Protein SP-C and SP-C-Promoted Membrane Fragmentation on Cholesterol Dynamics.Kinematic viscosity of therapeutic pulmonary surfactants with added polymers.Phase-field model for the morphology of monolayer lipid domains.Inhibition and counterinhibition of Surfacen, a clinical lung surfactant of natural originQuantitative lipidomic analysis of mouse lung during postnatal development by electrospray ionization tandem mass spectrometryHigh-throughput evaluation of pulmonary surfactant adsorption and surface film formation
P2860
Q26865690-C7F96B2B-D81A-4B97-894C-C93D8CBFB093Q28395117-F58C39F9-4738-4BB7-8C7F-22B41A13476EQ28481207-5EDFF611-B3D0-4F47-8441-BE506F998269Q28833705-29051302-417C-4405-9DCA-086BD6856114Q30453426-987C5C5B-EB10-46F0-BABB-A33281DCA350Q30480082-50405C2C-462D-4A18-965E-3F125418306CQ30489870-909E2850-3F23-4804-AE7E-4DEC434B0999Q33396842-70414201-9C0D-4EC6-9CF6-5F936A11A3F2Q33414437-EFD89C44-A9F2-406B-A677-8133B9381779Q33774273-3D5A80E5-2E99-4FD8-8BC1-44A6FBC52E20Q33813691-4086E924-6339-4EC2-8A85-71FAC8183ADEQ34536194-0E0A9999-9180-4690-881D-323E97E01486Q35346235-083CD131-2FFD-4D99-9239-68B6C356730DQ35769953-F2FAF66B-871D-4427-AB80-CFA79E1C7554Q36572921-84447891-8510-4AE2-B4DC-69D21D47043FQ36695369-07FBA84C-3CB8-4920-935B-169111828458Q36849340-E59DC47D-D2E5-4EFA-B8AC-68E5C1B9352EQ37181616-C84D92D6-028B-45A7-81C7-C4F6AC09F74FQ37226241-6E675589-20F0-4908-BB20-98C6606DBBCCQ37341712-979164CA-D0E5-4FD6-BA8C-8098629DC922Q37596427-97C02E90-16C7-4602-AD34-C604DD1B2C10Q37669627-F48F24A6-17F4-44FD-9DF3-CAE15C6B3553Q38045186-85006346-1CEF-4E12-BAE4-0CA9B60CDDF6Q38840748-2158566F-305F-4961-AECE-ACEF9EC9ADC1Q39028027-D1A16A70-9EB0-47F2-AF17-D2A826F2AAB8Q39192476-776BC887-7048-4919-B772-E87157E47FE1Q39816568-1D92CD91-0E69-4577-8F7B-53AB8BB67C5EQ40808883-93A192E3-B89E-480C-A840-0D93A55AF3BEQ41097884-A34D4AC4-6300-4D94-807E-F6D1FC668F47Q41836928-808679AA-A4DD-450F-AC5E-A57A14F54728Q41843692-8325FAF3-367B-4C43-811D-F1E7690D6C32Q41850314-C0FF6AA3-F000-429A-A2CB-FB1BF6F5A0D1Q41916387-5A9BA440-E779-421C-B258-EF6434EEC49FQ42364805-FD64B87D-D704-4C43-BF82-C617AD81E2DFQ42381304-620F1155-307E-44DB-86A5-0E5EBCB04F1BQ43143138-0E58FF4F-FD02-4548-8B1B-694C0475E5A4Q50800657-4F793D85-7726-4DFB-AE34-8C927BA8BA65Q58713589-A0FDBDFD-B5A0-4241-8246-371E1DB448AAQ58760114-0CA207CC-32EC-417A-AB5F-238D0D950A9AQ58831459-430642C3-1277-43A4-9B8A-9399EC8DD183
P2860
Biochemical and pharmacological differences between preparations of exogenous natural surfactant used to treat Respiratory Distress Syndrome: role of the different components in an efficient pulmonary surfactant.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Biochemical and pharmacologica ...... fficient pulmonary surfactant.
@en
type
label
Biochemical and pharmacologica ...... fficient pulmonary surfactant.
@en
prefLabel
Biochemical and pharmacologica ...... fficient pulmonary surfactant.
@en
P1476
Biochemical and pharmacologica ...... efficient pulmonary surfactant
@en
P2093
Odalys Blanco
P356
10.1016/J.EJPHAR.2007.04.035
P407
P577
2007-04-30T00:00:00Z